212 related articles for article (PubMed ID: 22232431)
1. Substratum topography modulates corneal fibroblast to myofibroblast transformation.
Myrna KE; Mendonsa R; Russell P; Pot SA; Liliensiek SJ; Jester JV; Nealey PF; Brown D; Murphy CJ
Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):811-6. PubMed ID: 22232431
[TBL] [Abstract][Full Text] [Related]
2. Substratum compliance modulates corneal fibroblast to myofibroblast transformation.
Dreier B; Thomasy SM; Mendonsa R; Raghunathan VK; Russell P; Murphy CJ
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5901-7. PubMed ID: 23860754
[TBL] [Abstract][Full Text] [Related]
3. Modulation of human corneal stromal cell differentiation by hepatocyte growth factor and substratum compliance.
Miyagi H; Jalilian I; Murphy CJ; Thomasy SM
Exp Eye Res; 2018 Nov; 176():235-242. PubMed ID: 30193807
[TBL] [Abstract][Full Text] [Related]
4. Latrunculin B and substratum stiffness regulate corneal fibroblast to myofibroblast transformation.
Thomasy SM; Raghunathan VK; Miyagi H; Evashenk AT; Sermeno JC; Tripp GK; Morgan JT; Murphy CJ
Exp Eye Res; 2018 May; 170():101-107. PubMed ID: 29421383
[TBL] [Abstract][Full Text] [Related]
5. Decorin transfection suppresses profibrogenic genes and myofibroblast formation in human corneal fibroblasts.
Mohan RR; Gupta R; Mehan MK; Cowden JW; Sinha S
Exp Eye Res; 2010 Aug; 91(2):238-45. PubMed ID: 20546727
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of Hsp90 inhibition on corneal cells in vitro and in vivo.
Raghunathan V; Edwards SG; Leonard BC; Kim S; Evashenk AT; Song Y; Rewinski E; Marangakis Price A; Hoehn A; Chang C; Reilly CM; Muppala S; Murphy CJ; Thomasy SM
Exp Eye Res; 2021 Jan; 202():108362. PubMed ID: 33220237
[TBL] [Abstract][Full Text] [Related]
7. Stromal haze, myofibroblasts, and surface irregularity after PRK.
Netto MV; Mohan RR; Sinha S; Sharma A; Dupps W; Wilson SE
Exp Eye Res; 2006 May; 82(5):788-97. PubMed ID: 16303127
[TBL] [Abstract][Full Text] [Related]
8. Role of
Gupta S; Martin LM; Sinha NR; Smith KE; Sinha PR; Dailey EM; Hesemann NP; Mohan RR
Mol Vis; 2020; 26():742-756. PubMed ID: 33273801
[TBL] [Abstract][Full Text] [Related]
9. Corneal myofibroblast viability: opposing effects of IL-1 and TGF beta1.
Kaur H; Chaurasia SS; Agrawal V; Suto C; Wilson SE
Exp Eye Res; 2009 Aug; 89(2):152-8. PubMed ID: 19285499
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin inhibits the production of myofibroblasts and reduces corneal scarring after photorefractive keratectomy.
Milani BY; Milani FY; Park DW; Namavari A; Shah J; Amirjamshidi H; Ying H; Djalilian AR
Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7424-30. PubMed ID: 24106124
[TBL] [Abstract][Full Text] [Related]
11. Nanoscale topography-induced modulation of fundamental cell behaviors of rabbit corneal keratocytes, fibroblasts, and myofibroblasts.
Pot SA; Liliensiek SJ; Myrna KE; Bentley E; Jester JV; Nealey PF; Murphy CJ
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1373-81. PubMed ID: 19875665
[TBL] [Abstract][Full Text] [Related]
12. Effect of TGFβ and PDGF-B blockade on corneal myofibroblast development in mice.
Singh V; Santhiago MR; Barbosa FL; Agrawal V; Singh N; Ambati BK; Wilson SE
Exp Eye Res; 2011 Dec; 93(6):810-7. PubMed ID: 21978952
[TBL] [Abstract][Full Text] [Related]
13. Myofibroblast differentiation of normal human keratocytes and hTERT, extended-life human corneal fibroblasts.
Jester JV; Huang J; Fisher S; Spiekerman J; Chang JH; Wright WE; Shay JW
Invest Ophthalmol Vis Sci; 2003 May; 44(5):1850-8. PubMed ID: 12714615
[TBL] [Abstract][Full Text] [Related]
14. Myofibroblast differentiation modulates keratocyte crystallin protein expression, concentration, and cellular light scattering.
Jester JV; Brown D; Pappa A; Vasiliou V
Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):770-8. PubMed ID: 22247459
[TBL] [Abstract][Full Text] [Related]
15. The corneal fibrosis response to epithelial-stromal injury.
Torricelli AA; Santhanam A; Wu J; Singh V; Wilson SE
Exp Eye Res; 2016 Jan; 142():110-8. PubMed ID: 26675407
[TBL] [Abstract][Full Text] [Related]
16. Electrophilic PPARγ ligands inhibit corneal fibroblast to myofibroblast differentiation in vitro: a potentially novel therapy for corneal scarring.
Kuriyan AE; Lehmann GM; Kulkarni AA; Woeller CF; Feldon SE; Hindman HB; Sime PJ; Huxlin KR; Phipps RP
Exp Eye Res; 2012 Jan; 94(1):136-45. PubMed ID: 22178289
[TBL] [Abstract][Full Text] [Related]
17. Optical effects of anti-TGFbeta treatment after photorefractive keratectomy in a cat model.
Bühren J; Nagy L; Swanton JN; Kenner S; MacRae S; Phipps RP; Huxlin KR
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):634-43. PubMed ID: 18952913
[TBL] [Abstract][Full Text] [Related]
18. TRPV1 potentiates TGFβ-induction of corneal myofibroblast development through an oxidative stress-mediated p38-SMAD2 signaling loop.
Yang Y; Wang Z; Yang H; Wang L; Gillespie SR; Wolosin JM; Bernstein AM; Reinach PS
PLoS One; 2013; 8(10):e77300. PubMed ID: 24098582
[TBL] [Abstract][Full Text] [Related]
19. Neutralizing antibody to TGFbeta modulates stromal fibrosis but not regression of photoablative effect following PRK.
Møller-Pedersen T; Cavanagh HD; Petroll WM; Jester JV
Curr Eye Res; 1998 Jul; 17(7):736-47. PubMed ID: 9678420
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Human Corneal Myofibroblast Formation.
Guo X; Sriram S; Tran JA; Hutcheon AEK; Zieske JD
Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3511-3520. PubMed ID: 30025094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
